These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38290200)

  • 1. Repositioning FDA-Approved Drug Against Chagas Disease and Cutaneous Leishmaniosis by Structure-Based Virtual Screening.
    Juarez-Saldivar A; Gómez-Escobedo R; Corral-Ruiz G; Chacón-Vargas KF; Horta-Montaño V; Sanchez-Torres L; Vazquez-Jimenez LK; Nogueda-Torres B; Rivera G
    Arch Med Res; 2024 Feb; 55(2):102958. PubMed ID: 38290200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
    Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
    Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in the Development of Triose Phosphate Isomerase Inhibitors as Antiprotozoal Agents.
    Vázquez-Jiménez LK; Moreno-Herrera A; Juárez-Saldivar A; González-González A; Ortiz-Pérez E; Paz-González AD; Palos I; Ramírez-Moreno E; Rivera G
    Curr Med Chem; 2022; 29(14):2504-2529. PubMed ID: 34517794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational Drug Repositioning for Chagas Disease Using Protein-Ligand Interaction Profiling.
    Juárez-Saldivar A; Schroeder M; Salentin S; Haupt VJ; Saavedra E; Vázquez C; Reyes-Espinosa F; Herrera-Mayorga V; Villalobos-Rocha JC; García-Pérez CA; Campillo NE; Rivera G
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-Anti-Parasitic Activity of Arylidene Ketones and Thiazolidene Hydrazines against Trypanosoma cruzi and Leishmania spp.
    Álvarez G; Perdomo C; Coronel C; Aguilera E; Varela J; Aparicio G; Zolessi FR; Cabrera N; Vega C; Rolón M; Rojas de Arias A; Pérez-Montfort R; Cerecetto H; González M
    Molecules; 2017 May; 22(5):. PubMed ID: 28481276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and characterization of a pyridine-2-thiol N-oxide gold(I) complex with potent antiproliferative effect against Trypanosoma cruzi and Leishmania sp. insight into its mechanism of action.
    Vieites M; Smircich P; Guggeri L; Marchán E; Gómez-Barrio A; Navarro M; Garat B; Gambino D
    J Inorg Biochem; 2009 Oct; 103(10):1300-6. PubMed ID: 19361864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Furan derivatives impair proliferation and affect ultrastructural organization of Trypanosoma cruzi and Leishmania amazonensis.
    Zuma AA; Teixeira de Macedo-Silva S; Achari A; Vinayagam J; Bhattacharjee P; Chatterjee S; Gupta VK; Cristina de Sousa Leite A; Souza de Castro L; Jaisankar P; de Souza W
    Exp Parasitol; 2021 May; 224():108100. PubMed ID: 33744229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In pursuit of drugs for American trypanosomiasis: evaluation of some "standards" in a mouse model.
    Kinnamon KE; Poon BT; Hanson WL; Waits VB
    Proc Soc Exp Biol Med; 1997 Dec; 216(3):424-8. PubMed ID: 9402149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent and Selective Inhibitors of Trypanosoma cruzi Triosephosphate Isomerase with Concomitant Inhibition of Cruzipain: Inhibition of Parasite Growth through Multitarget Activity.
    Aguilera E; Varela J; Birriel E; Serna E; Torres S; Yaluff G; de Bilbao NV; Aguirre-López B; Cabrera N; Díaz Mazariegos S; de Gómez-Puyou MT; Gómez-Puyou A; Pérez-Montfort R; Minini L; Merlino A; Cerecetto H; González M; Alvarez G
    ChemMedChem; 2016 Jun; 11(12):1328-38. PubMed ID: 26492824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of Antiprotozoal 2-(4-Alkyloxyphenyl)-Imidazolines and Imidazoles and Their Evaluation on
    Torres-Jaramillo J; Blöcher R; Chacón-Vargas KF; Hernández-Calderón J; Sánchez-Torres LE; Nogueda-Torres B; Reyes-Arellano A
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Docking-Based Virtual Screening of FDA-Approved Drugs Using Trypanothione Reductase Identified New Trypanocidal Agents.
    Gómez-Escobedo R; Méndez-Álvarez D; Vázquez C; Saavedra E; Vázquez K; Alcántara-Farfán V; Cordero-Martínez J; Gonzalez-Gonzalez A; Rivera G; Nogueda-Torres B
    Molecules; 2024 Aug; 29(16):. PubMed ID: 39202874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring microalgal and cyanobacterial metabolites with antiprotozoal activity against Leishmania and Trypanosoma parasites.
    Matos ÂP; Saldanha-Corrêa FMP; Gomes RDS; Hurtado GR
    Acta Trop; 2024 Mar; 251():107116. PubMed ID: 38159713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Practical Green Synthesis and Biological Evaluation of Benzimidazoles Against Two Neglected Tropical Diseases: Chagas and Leishmaniasis.
    Bandyopadhyay D; Samano S; Villalobos-Rocha JC; Sanchez-Torres LE; Nogueda-Torres B; Rivera G; Banik BK
    Curr Med Chem; 2017; 24(41):4714-4725. PubMed ID: 23317160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel prenyloxy chalcones as potential leishmanicidal and trypanocidal agents: Design, synthesis and evaluation.
    Espinoza-Hicks JC; Chacón-Vargas KF; Hernández-Rivera JL; Nogueda-Torres B; Tamariz J; Sánchez-Torres LE; Camacho-Dávila A
    Eur J Med Chem; 2019 Apr; 167():402-413. PubMed ID: 30784876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel polyamine analogs with anti-protozoal activity by computer guided drug repositioning.
    Alberca LN; Sbaraglini ML; Balcazar D; Fraccaroli L; Carrillo C; Medeiros A; Benitez D; Comini M; Talevi A
    J Comput Aided Mol Des; 2016 Apr; 30(4):305-21. PubMed ID: 26891837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioactivity of synthetic peptides from Ecuadorian frog skin secretions against
    Proaño-Bolaños C; Morán-Marcillo G; Espinosa de Los Monteros-Silva N; Bermúdez-Puga S; Salazar MA; Blasco-Zúñiga A; Cuesta S; Molina C; Espinosa F; Meneses L; Rojas-Silva P; Zapata Mena S; Sáenz FE; Rivera I M; Costales JA
    Microbiol Spectr; 2024 Aug; 12(8):e0333923. PubMed ID: 39012112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New chemotypes as Trypanosoma cruzi triosephosphate isomerase inhibitors: a deeper insight into the mechanism of inhibition.
    Alvarez G; Martínez J; Aguirre-López B; Cabrera N; Pérez-Díaz L; de Gómez-Puyou MT; Gómez-Puyou A; Pérez-Montfort R; Garat B; Merlino A; González M; Cerecetto H
    J Enzyme Inhib Med Chem; 2014 Apr; 29(2):198-204. PubMed ID: 23406473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germacranolide-type sesquiterpene lactones from Smallanthus sonchifolius with promising activity against Leishmania mexicana and Trypanosoma cruzi.
    Ulloa JL; Spina R; Casasco A; Petray PB; Martino V; Sosa MA; Frank FM; Muschietti LV
    Parasit Vectors; 2017 Nov; 10(1):567. PubMed ID: 29132413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of quinazoline derivatives as anti-trypanosomatid and anti-plasmodial agents.
    Mendoza-Martínez C; Correa-Basurto J; Nieto-Meneses R; Márquez-Navarro A; Aguilar-Suárez R; Montero-Cortes MD; Nogueda-Torres B; Suárez-Contreras E; Galindo-Sevilla N; Rojas-Rojas Á; Rodriguez-Lezama A; Hernández-Luis F
    Eur J Med Chem; 2015; 96():296-307. PubMed ID: 25899334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repositioning FDA Drugs as Potential Cruzain Inhibitors from Trypanosoma cruzi: Virtual Screening, In Vitro and In Vivo Studies.
    Palos I; Lara-Ramirez EE; Lopez-Cedillo JC; Garcia-Perez C; Kashif M; Bocanegra-Garcia V; Nogueda-Torres B; Rivera G
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28629155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.